Compare ANL & EVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ANL | EVN |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 406.5M | 430.6M |
| IPO Year | 2022 | 1998 |
| Metric | ANL | EVN |
|---|---|---|
| Price | $15.68 | $10.57 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 350.7K | 108.3K |
| Earning Date | 04-20-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.88 | $9.75 |
| 52 Week High | $13.00 | $11.23 |
| Indicator | ANL | EVN |
|---|---|---|
| Relative Strength Index (RSI) | 80.26 | 49.35 |
| Support Level | $1.36 | $10.16 |
| Resistance Level | N/A | $11.15 |
| Average True Range (ATR) | 1.38 | 0.14 |
| MACD | 0.70 | 0.05 |
| Stochastic Oscillator | 99.31 | 81.36 |
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.